Lista de obras - Frank R. Lichtenberg - Dominio Público Uruguay

Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? A reexamination using data from the U.S. and Australia ⬇️

artículo científico publicado en 2010

Benefits and Costs of Newer Drugs: An Update ⬇️

artículo científico publicado en 2002

Computer Use and Productivity Growth in Federal Government Agencies, 1987 to 1992 ⬇️

artículo científico publicado en 1996

Does Misery Love Company? Evidence from pharmaceutical markets before and after the Orphan Drug Act ⬇️

artículo científico publicado en 2003

Errors of Measurement in Output Deflators ⬇️

artículo científico publicado en 1986

Government Subsidies to Private Military R&D Investment: DOD's IR&D Policy ⬇️

scholarly article published October 1988

Has medical innovation reduced cancer mortality? ⬇️

artículo científico publicado en 2010

Have Newer Cardiovascular Drugs Reduced Hospitalization? Evidence From Longitudinal Country-Level Data on 20 OECD Countries, 1995-2003 ⬇️

artículo científico publicado en 2008

How Elastic is the Government's Demand for Weapons? ⬇️

artículo científico publicado en 1989

How Many Life-Years Have New Drugs Saved? A 3-Way Fixed-Effects Analysis of 66 Diseases in 27 Countries, 2000-2013 ⬇️

artículo científico publicado en 2019

IR&D Project Data and Theories of R&D Investment ⬇️

Importation and Innovation ⬇️

Industrial De-Diversification and its Consequences for Productivity ⬇️

artículo científico publicado en 1990

International R&D Spillovers: A Re-Examination ⬇️

artículo científico publicado en 1996

Labor Market Institutions, Liquidity Constraints, and Macroeconomic Stability ⬇️

Listen to your Doctor, or else!: Medication Under-use and Overuse and Long-term Health Outcomes of Danish Diabetes Patients ⬇️

artículo científico publicado en 2015

Ownership Structure and Corporate Performance in Japan ⬇️

artículo científico publicado en 1992

Pharmaceutical Innovation and Longevity Growth in 30 Developing and High-income Countries, 2000-2009 ⬇️

artículo científico publicado en 2012

Pharmaceutical Innovation, Mortality Reduction, and Economic Growth ⬇️

artículo científico publicado en 1998

Pharmaceutical innovation and the longevity of Australians: a first look ⬇️

artículo científico publicado en 2008

Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as "equipment for your health" ⬇️

artículo científico publicado en 2002

Private Investment in R&D to Signal Ability to Perform Government Contracts ⬇️

artículo científico publicado en 1986

R and D and Productivity at the Industry Level: Is There Still a Relationship? ⬇️

artículo científico publicado en 1982

R&D Investment and International Productivity Differences ⬇️

artículo científico publicado en 1992

Sources of U.S. Longevity Increase, 1960-1997 ⬇️

artículo científico publicado en 2002

Technical Change, Learning, and Wages ⬇️

artículo científico publicado en 1988

The Allocation of Publicly-Funded Biomedical Research ⬇️

artículo científico publicado en 1998

The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey ⬇️

artículo científico publicado en 2001

The Comparative Advantage of Educated Workers in Implementing New Technology: Some Empirical Evidence ⬇️

artículo científico publicado en 1985

The Dual Effects of Intellectual Property Regulations: Within- and Between- Patent Competition in the US Pharmaceuticals Industry ⬇️

artículo científico publicado en 2002

The Effect of Changes in Drug Utilization on Labor Supply and Per Capita Output ⬇️

artículo científico publicado en 2002

The Effect of Drug Vintage on Survival: Micro Evidence from Puerto Rico's Medicaid Program ⬇️

artículo científico publicado en 2004

The Effect of Education on Medical Technology Adoption: Are the More Educated More Likely to Use New Drugs ⬇️

artículo científico publicado en 2002

The Effect of New Drugs on Mortality from Rare Diseases and HIV ⬇️

article published in 2001

The Effect of New Political Administration on Federal Government Productivity and Employment ⬇️

artículo científico publicado en 1996

The Effect of Pharmaceutical Innovation on Longevity: Patient-Level Evidence from the 1996-2002 Medical Expenditure Panel Survey and Linked Mortality Public-Use Files ⬇️

artículo científico publicado en 2012

The Effect of Pharmaceutical Innovation on the Functional Limitations of Elderly Americans Evidence from the 2004 National Nursing Home Survey ⬇️

artículo científico publicado en 2012

The Effect of Pharmaceutical Utilization and Innovation on Hospitalization and Mortality ⬇️

artículo científico publicado en 1996

The Effect of Takeovers on the Employment and Wages of Central-Office and Other Personnel ⬇️

artículo científico publicado en 1989

The Effects of Leveraged Buyouts on Productivity and Related Aspects of Firm Behavior ⬇️

artículo científico publicado en 1989

The Effects of Mergers on Prices, Costs, and Capacity Utilization in the U.S. Air Transportation Industry, 1970-84 ⬇️

artículo científico publicado en 1989

The Expanding Pharmaceutical Arsenal in the War on Cancer ⬇️

artículo científico publicado en 2004

The Impact and Organization of Publicly-Funded Research and Development in the European Community ⬇️

artículo científico publicado en 1997

The Impact of Biomedical Knowledge Accumulation on Mortality: A Bibliometric Analysis of Cancer Data ⬇️

artículo científico publicado en 2013

The Impact of Increased Utilization of HIV Drugs on Longevity and Medical Expenditures: An Assessment Based on Aggregate U.S. Time-Series Data ⬇️

artículo científico publicado en 2006

The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries ⬇️

artículo científico publicado en 2018

The Impact of New Laboratory Procedures and Other Medical Innovations on the Health of Americans, 1990-2003: Evidence from Longitudinal, Disease-Level Data ⬇️

artículo científico publicado en 2006

The Impact of Pharmaceutical Innovation on Premature Cancer Mortality in Canada, 2000-2011 ⬇️

artículo científico publicado en 2015

The Impact of Public and Private Research Support on Premature Cancer Mortality and Hospitalization in the U.S., 1999-2013 ⬇️

artículo científico publicado en 2017

The Impact of R&D Investment On Productivity - New Evidence Using Linked R&D-LRD Data ⬇️

artículo científico publicado en 1989

The Impact of Therapeutic Procedure Innovation on Hospital Patient Longevity: Evidence from Western Australia, 2000-2007 ⬇️

artículo científico publicado en 2011

The Long-run Impact of New Medical Ideas on Cancer Survival and Mortality ⬇️

artículo científico publicado en 2018

The Output Contributions of Computer Equipment and Personnel: A Firm- Level Analysis ⬇️

artículo científico publicado en 1993

The Quality of Medical Care, Behavioral Risk Factors, and Longevity Growth ⬇️

artículo científico publicado en 2009

The impact of new drug launches on longevity: evidence from longitudinal disease-level data from 52 countries, 1982-2001 ⬇️

artículo científico publicado en 2003

Training, Tenure, and Productivity ⬇️

artículo científico publicado en 1981

Lista de obras de Frank R. Lichtenberg

Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? A reexamination using data from the U.S. and Australia ⬇️

Benefits and Costs of Newer Drugs: An Update ⬇️

Computer Use and Productivity Growth in Federal Government Agencies, 1987 to 1992 ⬇️

Does Misery Love Company? Evidence from pharmaceutical markets before and after the Orphan Drug Act ⬇️

Errors of Measurement in Output Deflators ⬇️

Government Subsidies to Private Military R&D Investment: DOD's IR&D Policy ⬇️

Has medical innovation reduced cancer mortality? ⬇️

Have Newer Cardiovascular Drugs Reduced Hospitalization? Evidence From Longitudinal Country-Level Data on 20 OECD Countries, 1995-2003 ⬇️

How Elastic is the Government's Demand for Weapons? ⬇️

How Many Life-Years Have New Drugs Saved? A 3-Way Fixed-Effects Analysis of 66 Diseases in 27 Countries, 2000-2013 ⬇️

IR&D Project Data and Theories of R&D Investment ⬇️

Importation and Innovation ⬇️

Industrial De-Diversification and its Consequences for Productivity ⬇️

International R&D Spillovers: A Re-Examination ⬇️

Labor Market Institutions, Liquidity Constraints, and Macroeconomic Stability ⬇️

Listen to your Doctor, or else!: Medication Under-use and Overuse and Long-term Health Outcomes of Danish Diabetes Patients ⬇️

Ownership Structure and Corporate Performance in Japan ⬇️

Pharmaceutical Innovation and Longevity Growth in 30 Developing and High-income Countries, 2000-2009 ⬇️

Pharmaceutical Innovation, Mortality Reduction, and Economic Growth ⬇️

Pharmaceutical innovation and the longevity of Australians: a first look ⬇️

Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as "equipment for your health" ⬇️

Private Investment in R&D to Signal Ability to Perform Government Contracts ⬇️

R and D and Productivity at the Industry Level: Is There Still a Relationship? ⬇️

R&D Investment and International Productivity Differences ⬇️

Sources of U.S. Longevity Increase, 1960-1997 ⬇️

Technical Change, Learning, and Wages ⬇️

The Allocation of Publicly-Funded Biomedical Research ⬇️

The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey ⬇️

The Comparative Advantage of Educated Workers in Implementing New Technology: Some Empirical Evidence ⬇️

The Dual Effects of Intellectual Property Regulations: Within- and Between- Patent Competition in the US Pharmaceuticals Industry ⬇️

The Effect of Changes in Drug Utilization on Labor Supply and Per Capita Output ⬇️

The Effect of Drug Vintage on Survival: Micro Evidence from Puerto Rico's Medicaid Program ⬇️

The Effect of Education on Medical Technology Adoption: Are the More Educated More Likely to Use New Drugs ⬇️

The Effect of New Drugs on Mortality from Rare Diseases and HIV ⬇️

The Effect of New Political Administration on Federal Government Productivity and Employment ⬇️

The Effect of Pharmaceutical Innovation on Longevity: Patient-Level Evidence from the 1996-2002 Medical Expenditure Panel Survey and Linked Mortality Public-Use Files ⬇️

The Effect of Pharmaceutical Innovation on the Functional Limitations of Elderly Americans Evidence from the 2004 National Nursing Home Survey ⬇️

The Effect of Pharmaceutical Utilization and Innovation on Hospitalization and Mortality ⬇️

The Effect of Takeovers on the Employment and Wages of Central-Office and Other Personnel ⬇️

The Effects of Leveraged Buyouts on Productivity and Related Aspects of Firm Behavior ⬇️

The Effects of Mergers on Prices, Costs, and Capacity Utilization in the U.S. Air Transportation Industry, 1970-84 ⬇️

The Expanding Pharmaceutical Arsenal in the War on Cancer ⬇️

The Impact and Organization of Publicly-Funded Research and Development in the European Community ⬇️

The Impact of Biomedical Knowledge Accumulation on Mortality: A Bibliometric Analysis of Cancer Data ⬇️

The Impact of Increased Utilization of HIV Drugs on Longevity and Medical Expenditures: An Assessment Based on Aggregate U.S. Time-Series Data ⬇️

The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries ⬇️

The Impact of New Laboratory Procedures and Other Medical Innovations on the Health of Americans, 1990-2003: Evidence from Longitudinal, Disease-Level Data ⬇️

The Impact of Pharmaceutical Innovation on Premature Cancer Mortality in Canada, 2000-2011 ⬇️

The Impact of Public and Private Research Support on Premature Cancer Mortality and Hospitalization in the U.S., 1999-2013 ⬇️

The Impact of R&D Investment On Productivity - New Evidence Using Linked R&D-LRD Data ⬇️

The Impact of Therapeutic Procedure Innovation on Hospital Patient Longevity: Evidence from Western Australia, 2000-2007 ⬇️

The Long-run Impact of New Medical Ideas on Cancer Survival and Mortality ⬇️

The Output Contributions of Computer Equipment and Personnel: A Firm- Level Analysis ⬇️

The Quality of Medical Care, Behavioral Risk Factors, and Longevity Growth ⬇️

The impact of new drug launches on longevity: evidence from longitudinal disease-level data from 52 countries, 1982-2001 ⬇️

Training, Tenure, and Productivity ⬇️